Urine and plasma pharmacokinetics of codeine in healthy volunteers: Implications for drugs-of-abuse testing

Journal of Analytical Toxicology

Volumn 20, Issue 7, 1996, Pages 541-546

  Lafolie, Pierre ^a   Beck, Olof ^a   Lin, Zhen ^a   Albertioni, Freidoun ^a   Boréus, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CODEINE 6 GLUCURONIDE; CODEINE PHOSPHATE; DRUG METABOLITE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; TRIMETHYLSILYL DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MONITORING; DRUG SCREENING; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NARCOTIC DEPENDENCE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029817541     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/20.7.541     Document Type: Article

References (20)

1. Mandatory guidelines for federal workplace drug-testing programs. Fed. Register. 59: 29903-31 (1994).
2. M.A. ElSohly and A.B. Jones. Morphine and codeine in biological fluids: Approaches to source differentiation. Forensic Sci. Rev. 1: 13-21 (1989).
3. T.K. Adler, J.M. Fujimoto, E.L. Way, and E.M. Baker. The metabolic fate of codeine in man. J. Pharmacol. Exp. Ther. 114: 251-62 (1955).
4. Z.R. Chen, A.A. Somogyi, and F. Bochner. Polymorphic O-demethylation of codeine. Lancet 11: 914-15 (1988).
5. Q.Y. Yue, J.O. Svensson, C. Alm, F. Sjöqvist, and J. Säwe. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br. J. Clin. Pharmacol. 28: 629-45 (1989).
6. Z.R. Chen, A.A. Somogyi, C. Reynolds, and F. Bochner. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br. J. Clin. Pharmacol. 31: 381-90 (1991).
7. Q.Y. Yue, J. Hasselström, J.O. Svensson, and J. Säwe. Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: Comparison between extensive and poor hydroxylators of debrisoquine. Br. J. Clin. Pharmacol. 31: 635-42 (1991).
8. H. Quiding, P. Andersson, L.O. Boréus, and P.Å. Hynning. Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. Eur. J. Clin. Pharmacol. 30: 673-77 (1986).
9. K. Persson, M. Hammarlund-Udenaes, Ö. Mortimer, and A. Rane. The postoperative pharmacokinetics of codeine. Eur. J. Clin. Pharmacol. 42: 663-66 (1992).
10. T.B. Vree and C.P.W.G.M. Verwey-van Wissen. Pharmacokinetics and metabolism of codeine in humans. Biopharmacol. Drug Disp. 13: 445-60 (1992).
11. M.C. Dutt, D.S. Lo, D.L.K. Ng, and S. Woo. Gas chromatographic study of the urinary codeine-to-morphine ratios in controlled codeine consumption and in mass screening for opiate drugs. J. Chromatogr. 267: 117-24 (1983).
12. E.J. Cone, P. Welch, B.D. Paul, and J.M. Mitchell. Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. J. Anal. Toxicol. 15: 161-66 (1991).
13. Z. Lin, P. Lafolie, and O. Beck. Evaluation of analytical procedures for urinary codeine and morphine measurements. J. Anal. Toxicol. 18: 129-33 (1994).
14. J.O. Svensson. Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 375: 174-78 (1986).
15. Siphar User's Guide, version 4.0, Simed, Créteil, France.
16. C. Gomeni and R. Gomeni. SIPHAR: An integrated computer system for statistical and pharmacokinetic data analysis. In Proceedings of the 7th International Congress of Medical Informatics. A. Serio, R. O'Moore, A. Tardini, and F.H. Roger, Eds., European Federation for Medical Informatics, Rome, Italy, 1987, pp 507-16.
17. G. Alvan. Genetic polymorphisms in drug metabolism. J. Int. Med. 231: 571-73 (1992).
18. M.D. Solomon. A study of codeine metabolism. Clin. Toxicol. 7: 255-57 (1974).
19. P. Lafolie, O. Beck, G. Blennow, L. Boréus, S. Borg, C.E. Elwin, L. Karlsson, G. Odelius, and P. Hjemdahl. Importance of creatinine analyses of urine when screening for abused drugs. Clin. Chem. 37: 1927-31 (1991).
20. P. Lafolie, O. Beck, P. Hjemdahl, and S. Borg. Using relation between urinary cannabinoid and creatinine excretions to improve monitoring of abuser adherence to abstinence. Clin. Chem. 40: 170-71 (1994).